- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE profits fall less than expected
Other headlines:Varian woos China
GE profits fall less than expected
In a market that has come to expect bad news, GE's report April 16 that profits dropped only 36% was good news. The mega-conglomerate beat Wall Street expectations with net income that totaled $2.74 billion in the first quarter compared with $4.3 billion in the year-earlier period. But the news was hardly welcome to the healthcare industry, as GE Healthcare sales dropped 9%, underscoring continued weak demand in the global market for medical equipment. Jeff Immelt, GE's CEO and chairman, provided a positive outlook, saying that the company was positioning itself to lead in this "reset economy" by investing in growth, lowering cost, and generating cash. "We see great opportunity in a global economy that favors clean energy, affordable healthcare, and services that drive customer productivity," he told investors.
Varian woos China
Varian Medical Systems will showcase its line of PaxScan flat-panel x-ray image detectors for digital radiography among its other x-ray components at the China International Medical Equipment Fair meeting in Shenzhen, April 18 to 21. The tech spread is designed to direct attention to the company's newly established x-ray service center in Beijing.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
